Impact of Proteasome Inhibition on Anti-Donor HLA Antibody Production After Kidney Transplantation
Status:
Terminated
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if treating patients who have high levels of donor
specific alloantibodies post-transplant with bortezomib might prevent the development of
transplant glomerulopathy and preserve allograft function.